Drug Shortage Report for CASODEX
| Report ID | 35377 |
| Drug Identification Number | 02184478 |
| Brand name | CASODEX |
| Common or Proper name | bicalutamide |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BICALUTAMIDE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 tablets |
| ATC code | L02BB |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-01-04 |
| Estimated end date | 2018-02-16 |
| Actual end date | 2018-02-15 |
| Shortage status | Resolved |
| Updated date | 2018-02-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-02-16 | English | Compare |
| v6 | 2018-02-15 | French | Compare |
| v5 | 2018-02-15 | English | Compare |
| v4 | 2018-02-01 | French | Compare |
| v3 | 2018-02-01 | English | Compare |
| v2 | 2018-01-09 | French | Compare |
| v1 | 2018-01-09 | English | Compare |
Showing 1 to 7 of 7